Profile picture

Mr Peter Bronnum Nielsen

Aalborg University, Aalborg (Denmark)
Follow
Logo ESC

Contributor content

Time-trends of sex differences in stroke risk in atrial fibrillation: Are female patients still at higher risk today? A nationwide cohort study
Presentation
Time-trends of sex differences in stroke risk in atrial fibrillation: Are female patients still at higher risk today? A nationwide cohort study
Intracranial haemorrhage in patients with atrial fibrillation: we should still anticoagulate - pro
Presentation
Intracranial haemorrhage in patients with atrial fibrillation: we should still anticoagulate - pro
Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients
Presentation
Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients
Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study
Presentation
Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study
Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: The Danish Stroke Registry
Presentation
Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: The Danish Stroke Registry
Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry
Presentation
Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry
Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): a retrospective cohort study
Presentation
Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): a retrospective cohort study
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation:   Using a CHA2DS2-VA score rather than CHA2DS2-VASc
Presentation
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc
Patient with a CHA2DS2VASc score of 1: what to do?
Presentation
Patient with a CHA2DS2VASc score of 1: what to do?
Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)
Presentation
Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

ESC 365 is supported by